Pliant Therapeutics to present phase 1 trial data at AACR meeting

March 18, 2026 9:00 AM

Pliant Therapeutics Inc. (NASDAQ: PLRX) will present data from its Phase 1 clinical trial of PLN-101095 at the American Association ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found